NEOPLASMS, RECTAL
Clinical trials for NEOPLASMS, RECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, RECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, RECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise for untreated rectal cancer in chinese patients
Disease control OngoingThis study tests a drug called dostarlimab in 23 Chinese patients with a specific type of advanced rectal cancer (dMMR/MSI-H) that has not been treated before. The goal is to see if the drug can make the cancer disappear completely and stay gone for at least 12 months. Patients r…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 06:40 UTC
-
Immunotherapy may replace harsh treatments for some rectal cancers
Disease control OngoingThis study tests whether the immunotherapy drug dostarlimab alone can eliminate tumors in people with a specific type of advanced rectal cancer (dMMR/MSI-H) that has not been treated before. About 154 participants will receive the drug and be closely monitored. If the cancer disa…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 14, 2026 12:07 UTC